Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France-Reference-Cited by-同舟云学术

Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France

Published:2022-08 Issue:6 Volume:29 Page:448-452
ISSN:0929-693X
Container-title:Archives de Pédiatrie
language:en
Short-container-title:Archives de Pédiatrie

Author:

Minary K.,Tanne C.^ORCID,Kwon T.,Faudeux C.,Clave S.,Langevin L.,Pietrement C.^ORCID,Enoch C.^ORCID,Parmentier C.,Mariani-Kurkdjian P.,Weill FX.,Jones G.,Djouadi N.,Morin D.,Fila M.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference34 articles.

1. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome;Tarr;Lancet,2005

2. Hemolytic uremic syndrome;Mele;Semin Immunol,2014

3. Epidemic profile of Shigatoxin-producing Escherichia coli O104:H4 outbreak in Germany— Preliminary report;Frank;N Engl J Med,2011

4. Escherichia coli O157:H7: animal reservoir and sources of human infection;Ferens;Foodborne Pathog Dis,2011

5. Prevalence of carriage of Shiga toxin-producing Escherichia coli serotypes O157:H7, O26:H11, O103:H2, O111:H8, and O145:H28 among slaughtered adult cattle in France;Bibbal;Appl Environ Microbiol,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. O26 Polysaccharides as Key Players in Enteropathogenic E. coli Immune Evasion and Vaccine Development;International Journal of Molecular Sciences;2024-03-01

2. Genomic surveillance of STEC/EHEC infections in Germany 2020 to 2022 permits insight into virulence gene profiles and novel O-antigen gene clusters;International Journal of Medical Microbiology;2024-03

3. Cardiovascular impairment in Shiga-toxin-2-induced experimental hemolytic–uremic syndrome: a pilot study;Frontiers in Immunology;2023-09-22

4. The epidemiology of Shiga toxin-producing Escherichia coli O26:H11 (clonal complex 29) in England, 2014–2021;Journal of Infection;2023-06

5. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04